{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T15:50:56Z","timestamp":1725292256549},"reference-count":29,"publisher":"Japanese Society of Toxicology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2024]]},"DOI":"10.2131\/jts.49.269","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T22:22:53Z","timestamp":1717194173000},"page":"269-279","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of cardiohemodynamic and electrophysiological effects of morphine along with its toxicokinetic profile using the halothane-anesthetized dogs"],"prefix":"10.2131","volume":"49","author":[{"given":"Ai","family":"Goto","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Kambayashi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Fujishiro","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine, Faculty of Medicine, Showa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chika","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Izumi-Nakaseko","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Takei","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Kurosaki","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Anzai, T., Sato, T., Fukumoto, Y., Izumi, C., Kizawa, Y., Koga, M., Nishimura, K., Ohishi, M., Sakashita, A., Sakata, Y., Shiga, T., Takeishi, Y., Yasuda, S., Yamamoto, K., Abe, T., Akaho, R., Hamatani, Y., Hosoda, H., Ishimori, N., Kato, M., Kinugasa, Y., Kubozono, T., Nagai, T., Oishi, S., Okada, K., Shibata, T., Suzuki, A., Suzuki, T., Takagi, M., Takada, Y., Tsuruga, K., Yoshihisa, A., Yumino, D., Fukuda, K., Kihara, Y., Saito, Y., Sawa, Y., Tsutsui, H. and Kimura, T.; Japanese Circulation Society Joint Working Group. (2021): JCS\/JHFS 2021 statement on palliative care in cardiovascular diseases. Circ. J., <b>85<\/b>, 695-757.","DOI":"10.1253\/circj.CJ-20-1127"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Behzadi, M., Joukar, S. and Beik, A. (2018): Opioids and Cardiac Arrhythmia: A Literature Review. Med. Princ. Pract., <b>27<\/b>, 401-414.","DOI":"10.1159\/000492616"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Chen, A. and Ashburn, M.A. (2015): Cardiac Effects of Opioid Therapy. Pain Med., <b>16<\/b> (Suppl 1), S27-S31.","DOI":"10.1111\/pme.12915"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Feeney, C., Ani, C., Sharma, N. and Frohlich, T. (2011): Morphine-induced cardiogenic shock. Ann. Pharmacother., <b>45<\/b>, e30.","DOI":"10.1345\/aph.1Q022"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Goto, A., Kambayashi, R., Hagiwara-Nagasawa, M., Izumi-Nakaseko, H., Takei, Y., Kawai, S., Matsumoto, A., Lurie, K.G. and Sugiyama, A. (2022): Impact of head-up tilt on expiratory negative airway pressure ventilation-induced cardiovascular hemodynamics in the halothane-anesthetized intact microminipigs. Heart Vessels, <b>37<\/b>, 1808-1815.","DOI":"10.1007\/s00380-022-02068-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Goto, A., Kambayashi, R., Izumi-Nakaseko, H., Shinozaki, M., Takei, Y. and Sugiyama, A. (2023): Characterization of electropharmacological profile of an anti-atrial fibrillatory drug vernakalant along with potential risk toward torsade de pointes: translational studies using isoflurane-anesthetized dogs and isolated rat aortic preparations. J. Pharmacol. Sci., <b>152<\/b>, 201-209.","DOI":"10.1016\/j.jphs.2023.05.003"},{"key":"7","unstructured":"Greenberg, S., McGowan, C., Xie, J. and Summer, W.R. (1994): Selective pulmonary and venous smooth muscle relaxation by furosemide: a comparison with morphine. J. Pharmacol. Exp. Ther., <b>270<\/b>, 1077-1085."},{"key":"8","doi-asserted-by":"crossref","unstructured":"Hagiwara-Nagasawa, M., Kambayashi, R., Goto, A., Chiba, K., Wada, T., Nunoi, Y., Izumi-Nakaseko, H., Takei, Y., Matsumoto, A., Lurie, K.G. and Sugiyama, A. (2021): Effects of mechanical ventilation with expiratory negative airway pressure on porcine pulmonary and systemic circulation: mechano-physiology and potential application. J. Physiol. Sci., <b>71<\/b>, 17.","DOI":"10.1186\/s12576-021-00801-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Hung, C.F., Tsai, C.H. and Su, M.J. (1998): Opioid receptor independent effects of morphine on membrane currents in single cardiac myocytes. Br. J. Anaesth., <b>81<\/b>, 925-931.","DOI":"10.1093\/bja\/81.6.925"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Johannesen, L., Vicente, J., Mason, J.W., Sanabria, C., Waite-Labott, K., Hong, M., Guo, P., Lin, J., S\u00f8rensen, J.S., Galeotti, L., Florian, J., Ugander, M., Stockbridge, N. and Strauss, D.G. (2014): Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil. Clin. Pharmacol. Ther., <b>96<\/b>, 549-558.","DOI":"10.1038\/clpt.2014.155"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Johnson, M.J., McDonagh, T.A., Harkness, A., McKay, S.E. and Dargie, H.J. (2002): Morphine for the relief of breathlessness in patients with chronic heart failure--a pilot study. Eur. J. Heart Fail., <b>4<\/b>, 753-756.","DOI":"10.1016\/S1388-9842(02)00158-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Katchman, A.N., McGroary, K.A., Kilborn, M.J., Kornick, C.A., Manfredi, P.L., Woosley, R.L. and Ebert, S.N. (2002): Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(<sup>+<\/sup>) currents. J. Pharmacol. Exp. Ther., <b>303<\/b>, 688-694.","DOI":"10.1124\/jpet.102.038240"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Kawaguchi, J., Hamatani, Y., Hirayama, A., Nishimura, K., Nakai, E., Nakamura, E., Miyata, M., Kawano, Y., Takada, Y., Anchi, Y., Funabashi, S., Kuroda, K., Azechi, M., Takahama, H., Anzai, T., Yasuda, S., Kitaoka, H. and Izumi, C. (2020): Experience of morphine therapy for refractory dyspnea as palliative care in advanced heart failure patients. J. Cardiol., <b>75<\/b>, 682-688.","DOI":"10.1016\/j.jjcc.2019.12.015"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Kambayashi, R., Goto, A., Izumi-Nakaseko, H., Takei, Y. and Sugiyama, A. (2024): Characterization of cardiovascular profile of anti-influenza drug peramivir: A reverse-translational study using the isoflurane-anesthetized dog. J. Pharmacol. Sci., <b>154<\/b>, 218-224.","DOI":"10.1016\/j.jphs.2024.02.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Knox, C., Wilson, M., Klinger, C.M., Franklin, M., Oler, E., Wilson, A., Pon, A., Cox, J., Chin, N.E., Strawbridge, S.A., Garcia-Patino, M., Kruger, R., Sivakumaran, A., Sanford, S., Doshi, R., Khetarpal, N., Fatokun, O., Doucet, D., Zubkowski, A., Rayat, D.Y., Jackson, H., Harford, K., Anjum, A., Zakir, M., Wang, F., Tian, S., Lee, B., Liigand, J., Peters, H., Wang, R.Q., Nguyen, T., So, D., Sharp, M., da Silva, R., Gabriel, C., Scantlebury, J., Jasinski, M., Ackerman, D., Jewison, T., Sajed, T., Gautam, V. and Wishart, D.S. (2024): DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res., <b>52<\/b> (D1), D1265-D1275.","DOI":"10.1093\/nar\/gkad976"},{"key":"16","doi-asserted-by":"crossref","unstructured":"McDonagh, T.A., Metra, M., Adamo, M., Gardner, R.S., Baumbach, A., B\u00f6hm, M., Burri, H., Butler, J., \u010celutkien\u0117, J., Chioncel, O., Cleland, J.G.F., Coats, A.J.S., Crespo-Leiro, M.G., Farmakis, D., Gilard, M., Heymans, S., Hoes, A.W., Jaarsma, T., Jankowska, E.A., Lainscak, M., Lam, C.S.P., Lyon, A.R., McMurray, J.J.V., Mebazaa, A., Mindham, R., Muneretto, C., Francesco Piepoli, M., Price, S., Rosano, G.M.C., Ruschitzka, F. and Kathrine Skibelund, A.; ESC Scientific Document Group. (2021): 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J., <b>42<\/b>, 3599-3726.","DOI":"10.1093\/eurheartj\/ehab670"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Motomura, S. and Hashimoto, K. (1989): Histamine H<sub>2<\/sub>-receptor mediated positive dromotropic effect in the canine atrioventricular node. Jpn. J. Pharmacol., <b>49<\/b>, 325-335.","DOI":"10.1254\/jjp.49.325"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Nakamura, T., Nakamura, M., Kai, M., Shibasaki, Y., Tomita, H., Watabe, M., Yokokura, H. and Momomura, S.I. (2023): Clinical Use of Oral Opioid Therapy for Dyspnea in Patients With Advanced Heart Failure - A Single-Center Retrospective Study. Circ. Rep., <b>5<\/b>, 351-357.","DOI":"10.1253\/circrep.CR-23-0059"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Neumann, P.B., Henriksen, H., Grosman, N. and Christensen, C.B. (1982): Plasma morphine concentrations during chronic oral administration in patients with cancer pain. Pain, <b>13<\/b>, 247-252.","DOI":"10.1016\/0304-3959(82)90014-8"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Nogawa, H. and Kawai, T. (2014): hERG trafficking inhibition in drug-induced lethal cardiac arrhythmia. Eur. J. Pharmacol., <b>741<\/b>, 336-339.","DOI":"10.1016\/j.ejphar.2014.06.044"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Pugsley, M.K. (2002): The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system. Pharmacol. Ther., <b>93<\/b>, 51-75.","DOI":"10.1016\/S0163-7258(02)00165-1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Randich, A., Thurston, C.L., Ludwig, P.S., Timmerman, M.R. and Gebhart, G.F. (1991): Antinociception and cardiovascular responses produced by intravenous morphine: the role of vagal afferents. Brain Res., <b>543<\/b>, 256-270.","DOI":"10.1016\/0006-8993(91)90036-U"},{"key":"23","unstructured":"Schumacher, M.A., Basbaum, A.I. and Naidu, R.K. (2021): Opioid agonists &amp; antagonists. In: Basic &amp; clinical pharmacology, 15th ed. (Katzung, B.G. and Vanderah, T.W., eds.), pp.573-595, McGraw Hill Education, New York."},{"key":"24","doi-asserted-by":"crossref","unstructured":"Sein Anand, \u0141., Korolkiewicz, P.K. and Sein Anand, J. (2021): Cardiogenic shock induced by a high dose of intravenous morphine. Int. J. Occup. Med. Environ. Health, <b>34<\/b>, 133-138.","DOI":"10.13075\/ijomeh.1896.01629"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Sugiyama, A. and Hashimoto, K. (2002): Effects of a typical I(<sub>Kr<\/sub>) channel blocker sematilide on the relationship between ventricular repolarization, refractoriness and onset of torsades de pointes. Jpn. J. Pharmacol., <b>88<\/b>, 414-421.","DOI":"10.1254\/jjp.88.414"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Sugiyama, A. (2008): Sensitive and reliable proarrhythmia <i>in vivo<\/i> animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts. Br. J. Pharmacol., <b>154<\/b>, 1528-1537.","DOI":"10.1038\/bjp.2008.240"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Suzuki, N., Kambayashi, R., Goto, A., Izumi-Nakaseko, H., Takei, Y., Naito, A.T. and Sugiyama, A. (2023): Cardiovascular safety pharmacology of ivermectin assessed using the isoflurane-anesthetized beagle dogs: ICH S7B follow-up study. J. Toxicol. Sci., <b>48<\/b>, 645-654.","DOI":"10.2131\/jts.48.645"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Van de Water, A., Verheyen, J., Xhonneux, R. and Reneman, R.S. (1989): An improved method to correct the QT interval of the electrocardiogram for changes in heart rate. J. Pharmacol. Methods, <b>22<\/b>, 207-217.","DOI":"10.1016\/0160-5402(89)90015-6"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Yokoyama, H., Nakamura, Y., Iwasaki, H., Nagayama, Y., Hoshiai, K., Mitsumori, Y. and Sugiyama, A. (2009): Effects of acute intravenous administration of pentamidine, a typical hERG-trafficking inhibitor, on the cardiac repolarization process of halothane-anesthetized dogs. J. Pharmacol. Sci., <b>110<\/b>, 476-482.","DOI":"10.1254\/jphs.09071FP"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/49\/6\/49_269\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T04:27:45Z","timestamp":1717216065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/49\/6\/49_269\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.49.269","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}